Join to View Full Profile
450 Brookline AveBoston, MA 02215
Dr. Ahn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2013 - 2017
Houston Methodist Hospital (Medical Center)Residency, Internal Medicine, 2010 - 2013
Catholic University Medical CollegeClass of 2008, M.D.
Certifications & Licensure
MA State Medical License 2021 - 2026
NH State Medical License 2023 - 2025
MD State Medical License 2017 - 2022
DC State Medical License 2013 - 2017
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade.Reid W Merryman, Justin Kline, Robert A Redd, Harrison Olszewski, Emma Welsh
Blood Neoplasia. 2026-02-01 - Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL.Thomas Chatzikonstantinou, Mariia Mikhaleva, Christian Brieghel, Christina Papangelou, Eva Minga
Blood Advances. 2026-01-27 - A Decade of Ibrutinib for CLL with and without TP53 Aberration: Final Report on an Investigator-Sponsored Phase 2 Study.Andy Itsara, Victoria M Rogness, Laura Samples, Constance M Yuan, Hao-Wei Wang
Blood. 2025-12-17
Abstracts/Posters
- A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with IbrutinibInhye E Ahn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib Show Expansion of T-Cell Clonotypes Composed of Antitumor Cytotoxic CD8+ T-CellsInhye E Ahn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Whole Exome Sequencing Reveals Multiple Driver Events in Chronic Lymphocytic Leukemia Patients with Acquired Ibrutinib ResistanceInhye E Ahn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Clinically Indicated Ibrutinib Interruptions Do Not Limit Long-Term Benefit in CLLJune 27th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
